GLP 1 peptider med enorm betydning for hjerte-kar-systemet: Ny mekanisme opdaget!
From the study, the trial was supported by an Excellence grant from the Novo Nordisk Foundation (NNF16OC0019968), the Novo Nordisk Foundation Center for Basic Metabolic Research, the Novo Nordisk Foundation Tripartite Immunometabolism Consortium (NNF15CC0018486), Helsefonden, and a PhD grant from the Danish Diabetes Academy.